研究者
J-GLOBAL ID：200901009990380428
更新日: 2024年05月12日
熱田 由子
アツタ ヨシコ | Atsuta Yoshiko
所属機関・部署：
職名：
センター長
競争的資金等の研究課題 (3件)：
- 2011 - 2012 造血幹細胞移植後晩期障害と患者QOLに関する研究
- 2009 - 2011 アジアにおける造血細胞移植登録システムの構築
- 2007 - 2008 本邦における造血幹細胞移植後二次癌の頻度・リスクに関する研究
論文 (395件)：
-
Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Jun Aoki, Noriko Doki, Tetsuya Nishida, Takahiro Fukuda, Naoyuki Uchida, Yasunori Ueda, Yasufumi Uehara, et al. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy. Bone marrow transplantation. 2024
-
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Yoshiko Atsuta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, et al. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission. American journal of hematology. 2024. 99. 5. 806-815
-
Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, et al. Impact of Early Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients with Myelodysplastic Syndrome: A Nationwide Retrospective Study from Adult Myelodysplastic Syndrome Working Group of the JSTCT. Transplantation and cellular therapy. 2024
-
Tomoyasu Jo, Tomoaki Ueda, Yu Akahoshi, Tadakazu Kondo, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Noriko Doki, Shuichi Ota, Masashi Sawa, et al. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 2024
-
Sho Shibata, Yasuyuki Arai, Tadakazu Kondo, Shohei Mizuno, Satoshi Yamasaki, Takashi Akasaka, Noriko Doki, Shuichi Ota, Yumiko Maruyama, Ken-Ichi Matsuoka, et al. Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia. Cytotherapy. 2024
もっと見る
MISC (101件)：
-
森 拓人, 越智 陽太郎, 昆 彩奈, 吉里 哲一, 古関 明彦, 依田 成玄, 中川 正宏, 竹田 淳恵, 永田 安伸, 吉田 健一, et al. 骨髄異形成症候群におけるSRSF2変異とSTAG2変異と協調的関係(Cooperative effects of SRSF2 and STAG2 mutations on development of myelodysplastic syndrome and its related disorders). 日本癌学会総会記事. 2022. 81回. IS11-6
-
Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, et al. Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD. 2021. 138. 3692-+
-
Yoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, Tadakazu Kondo, Shohei Mizuno, Junya Kanda, Takahiro Fujino, Keisuke Kataoka, Naoyuki Uchida, Tetsuya Eto, et al. Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia. BLOOD. 2021. 138. 1790-+
-
Kyoko Fuse, Masayoshi Masuko, Shohei Mizuno, Kaito Harada, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Kazuhiro Ikegame, et al. Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML. BLOOD. 2020. 136
-
Seitaro Terakura, Tetsuya Nishida, Masashi Sawa, Tomonori Kato, Kotaro Miyao, Yukiyasu Ozawa, Tatsunori Goto, Akio Kohno, Kazutaka Ozeki, Yasushi Onishi, et al. Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome. Bone marrow transplantation. 2020
もっと見る
経歴 (1件)：
- 名古屋大学 医学部 寄附講座 名古屋大学医学部寄附講座(医学部) 寄附講座講師
前のページに戻る
